+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammatory Pain Drug"

Inflammatory Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Inflammatory Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Inflammatory Pain - Epidemiology Forecast - 2032 - Product Thumbnail Image

Inflammatory Pain - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Immune Disorders Drugs market includes drugs used to treat inflammatory pain. These drugs are used to reduce inflammation and pain caused by a variety of conditions, including arthritis, lupus, and psoriasis. They work by blocking the production of certain chemicals that cause inflammation and pain. Commonly used drugs in this market include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics. NSAIDs are the most commonly used drugs, as they are effective in reducing inflammation and pain. Corticosteroids are used to reduce inflammation and pain in more severe cases, while biologics are used to treat autoimmune diseases. Some companies in the Immune Disorders Drugs market include Pfizer, Merck, AbbVie, and Johnson & Johnson. Show Less Read more